379 related articles for article (PubMed ID: 28884232)
1. [
Coakeley S; Cho SS; Koshimori Y; Rusjan P; Ghadery C; Kim J; Lang AE; Houle S; Strafella AP
Brain Struct Funct; 2018 Mar; 223(2):589-595. PubMed ID: 28884232
[TBL] [Abstract][Full Text] [Related]
2. Subcortical
Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
4. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy.
Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy.
Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP
J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586
[TBL] [Abstract][Full Text] [Related]
6. Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.
Taniguchi D; Hatano T; Kamagata K; Okuzumi A; Oji Y; Mori A; Hori M; Aoki S; Hattori N
Mov Disord; 2018 Sep; 33(9):1488-1492. PubMed ID: 29756366
[TBL] [Abstract][Full Text] [Related]
7. Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism.
Chougar L; Arsovic E; Gaurav R; Biondetti E; Faucher A; Valabrègue R; Pyatigorskaya N; Dupont G; Lejeune FX; Cormier F; Corvol JC; Vidailhet M; Degos B; Grabli D; Lehéricy S
Mov Disord; 2022 Jun; 37(6):1245-1255. PubMed ID: 35347754
[TBL] [Abstract][Full Text] [Related]
8. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.
Marquié M; Verwer EE; Meltzer AC; Kim SJW; Agüero C; Gonzalez J; Makaretz SJ; Siao Tick Chong M; Ramanan P; Amaral AC; Normandin MD; Vanderburg CR; Gomperts SN; Johnson KA; Frosch MP; Gómez-Isla T
Acta Neuropathol Commun; 2017 Oct; 5(1):75. PubMed ID: 29047416
[TBL] [Abstract][Full Text] [Related]
9. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
[TBL] [Abstract][Full Text] [Related]
10.
Smith R; Schöll M; Londos E; Ohlsson T; Hansson O
Sci Rep; 2018 Mar; 8(1):4717. PubMed ID: 29549278
[TBL] [Abstract][Full Text] [Related]
11. Tau Tangles in Parkinson's Disease: A 2-Year Follow-Up Flortaucipir PET Study.
Hansen AK; Parbo P; Ismail R; Østergaard K; Brooks DJ; Borghammer P
J Parkinsons Dis; 2020; 10(1):161-171. PubMed ID: 31815700
[TBL] [Abstract][Full Text] [Related]
12.
Schonhaut DR; McMillan CT; Spina S; Dickerson BC; Siderowf A; Devous MD; Tsai R; Winer J; Russell DS; Litvan I; Roberson ED; Seeley WW; Grinberg LT; Kramer JH; Miller BL; Pressman P; Nasrallah I; Baker SL; Gomperts SN; Johnson KA; Grossman M; Jagust WJ; Boxer AL; Rabinovici GD
Ann Neurol; 2017 Oct; 82(4):622-634. PubMed ID: 28980714
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ
Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
[TBL] [Abstract][Full Text] [Related]
14. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
[TBL] [Abstract][Full Text] [Related]
15. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.
Whitwell JL; Tosakulwong N; Schwarz CG; Botha H; Senjem ML; Spychalla AJ; Ahlskog JE; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
Mov Disord; 2019 Jan; 34(1):105-113. PubMed ID: 30468693
[TBL] [Abstract][Full Text] [Related]
16. Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy.
Ma JH; Dong C; Qiao HW; Barret O; Tamagnan GD; Mao W; Xu EH; Zhang C; Lu J; Chan P; Liu SY
Mov Disord; 2024 May; 39(5):847-854. PubMed ID: 38477228
[TBL] [Abstract][Full Text] [Related]
17. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
[TBL] [Abstract][Full Text] [Related]
18. The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases.
Vermeiren C; Motte P; Viot D; Mairet-Coello G; Courade JP; Citron M; Mercier J; Hannestad J; Gillard M
Mov Disord; 2018 Feb; 33(2):273-281. PubMed ID: 29278274
[TBL] [Abstract][Full Text] [Related]
19. Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD.
Kashihara K; Shinya T; Higaki F
Intern Med; 2011; 50(16):1683-7. PubMed ID: 21841326
[TBL] [Abstract][Full Text] [Related]
20. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]